CircRNA-UCK2 increased TET1 inhibits proliferation and invasion of prostate cancer cells via sponge miRNA-767-5p
A majority of the patients with advanced prostate cancer initially respond to androgen deprivation therapy and enzalutamide therapy, but eventually enter the castration-resistant prostate cancer (CRPC) phase. Some studies have shown that the activation of other signalling pathways in CRPC cells repl...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2019-11-01
|
Series: | Open Medicine |
Subjects: | |
Online Access: | http://www.degruyter.com/view/j/med.2019.14.issue-1/med-2019-0097/med-2019-0097.xml?format=INT |